CA2002208A1 - Methodes d'extraction pour preparer des reactifs de thromboplastine - Google Patents

Methodes d'extraction pour preparer des reactifs de thromboplastine

Info

Publication number
CA2002208A1
CA2002208A1 CA2002208A CA2002208A CA2002208A1 CA 2002208 A1 CA2002208 A1 CA 2002208A1 CA 2002208 A CA2002208 A CA 2002208A CA 2002208 A CA2002208 A CA 2002208A CA 2002208 A1 CA2002208 A1 CA 2002208A1
Authority
CA
Canada
Prior art keywords
extraction
thromboplastin reagents
thromboplastin
sensitivity
extraction methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2002208A
Other languages
English (en)
Other versions
CA2002208C (fr
Inventor
Pamela L. H. Hawkins
James R. Maynard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dade Behring Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of CA2002208A1 publication Critical patent/CA2002208A1/fr
Application granted granted Critical
Publication of CA2002208C publication Critical patent/CA2002208C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7454—Tissue factor (tissue thromboplastin, Factor III)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Compounds Of Unknown Constitution (AREA)
CA002002208A 1988-11-23 1989-11-03 Methodes d'extraction pour preparer des reactifs de thromboplastine Expired - Lifetime CA2002208C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27608388A 1988-11-23 1988-11-23
US07/276,083 1988-11-23

Publications (2)

Publication Number Publication Date
CA2002208A1 true CA2002208A1 (fr) 1990-05-23
CA2002208C CA2002208C (fr) 1998-02-24

Family

ID=23055093

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002002208A Expired - Lifetime CA2002208C (fr) 1988-11-23 1989-11-03 Methodes d'extraction pour preparer des reactifs de thromboplastine

Country Status (9)

Country Link
US (1) US5426031A (fr)
EP (1) EP0396733B1 (fr)
JP (1) JP3348228B2 (fr)
AT (1) ATE99697T1 (fr)
CA (1) CA2002208C (fr)
DE (1) DE68912115T2 (fr)
DK (1) DK173090A (fr)
NO (1) NO178578C (fr)
WO (1) WO1990005740A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
US5254350A (en) * 1991-07-22 1993-10-19 Helena Laboratories Corporation Method of preparing a thromboplastin extract
US5358853A (en) * 1992-08-03 1994-10-25 Akzo Av Liquid thromboplastin reagent
DE4407386B4 (de) * 1994-03-05 2009-01-15 Dade Behring Marburg Gmbh Verfahren zur Reaktivierung von gereinigten Membranproteinen durch Einfrieren
JPH08512139A (ja) * 1994-04-28 1996-12-17 デイド、インターナショナル、インコーポレイテッド プロトロンビン時間（ｐｔ）アッセイ用のキャリブレーター
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
DE69832628T2 (de) * 1997-04-23 2006-09-07 Instrumentation Laboratory S.P.A. Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
CA2342606A1 (fr) 1998-10-07 2000-04-13 Sigma-Aldrich Co. Reactifs de thromboplastine, procedes de preparation et d'utilisation correspondants
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
US20080260858A1 (en) * 2005-02-16 2008-10-23 The Board Of Trustees Of The University Of Illnois Universal Procoagulant
DE602006021290D1 (de) * 2005-03-04 2011-05-26 Univ Illinois Modulator von coagulationskaskaden und fibrinolytischen kaskaden
US8821861B2 (en) * 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (fr) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Antagoniste d'anticoagulant et procoagulant anti-hémophilique
CN112481355B (zh) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 液体型凝血酶原时间测定试剂盒及其制备方法
CN115166268B (zh) * 2022-08-02 2025-07-04 南京颐兰贝生物科技有限责任公司 一种凝血酶原时间检测试剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522148A (en) * 1965-08-13 1970-07-28 Dade Reagents Inc Stabilized thromboplastin preparation
JPS6366556A (ja) * 1986-09-09 1988-03-25 Fujitsu Ltd フオトマスクの修正方法
US5017556A (en) * 1986-11-04 1991-05-21 Genentech, Inc. Treatment of bleeding disorders using lipid-free tissue factor protein

Also Published As

Publication number Publication date
DE68912115T2 (de) 1994-08-11
EP0396733B1 (fr) 1994-01-05
NO178578B (no) 1996-01-15
ATE99697T1 (de) 1994-01-15
JP3348228B2 (ja) 2002-11-20
JPH03503534A (ja) 1991-08-08
DK173090D0 (da) 1990-07-19
DE68912115D1 (de) 1994-02-17
US5426031A (en) 1995-06-20
EP0396733A1 (fr) 1990-11-14
DK173090A (da) 1990-07-19
NO178578C (no) 1996-04-24
NO903261D0 (no) 1990-07-20
WO1990005740A1 (fr) 1990-05-31
NO903261L (no) 1990-07-20
CA2002208C (fr) 1998-02-24

Similar Documents

Publication Publication Date Title
CA2002208A1 (fr) Methodes d'extraction pour preparer des reactifs de thromboplastine
DE69801210D1 (de) Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern
ATE78098T1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
AU751525B2 (en) Method for determining the anticoagulatory potential of a sample
AU591465B2 (en) Methods for coagulation monitoring
ES2072243T1 (es) Prueba de coagulacion cuantitativa respecto a factor vii activo.
CA2032561A1 (fr) Methode pour determiner les concentrations de facteurs de coagulation extrinseques et intrinseques et celles de proteine c
WO1991002812A1 (fr) PROCEDE ET ANALYSE A INACTIVATION PAR LA PROTEINE C DES FACTEURS Va et VIIIa
JPH11225796A5 (fr)
Walenga et al. Newer avenues in the monitoring of antithrombotic therapy: The role of automation
DK0690991T4 (da) Ny antikoagulant-cofaktor-aktivitet
WO1998032389A1 (fr) Procede et appareil permettant de mesurer les proprietes de coagulation du sang au moyen de materiaux absorbants
Jude et al. Distinctive features of procoagulant response of monocytes from diabetic patients
Lippi et al. Preoperative screening: the rationale of measuring APTT in risk assessment
ES2090106T3 (es) Metodo de asociacion quimica directa de dimero d procedente de una muestra biologica y que permite el diagnostico y el seguimiento de estados de trombolisis y de hipercoagulabilidad.
ATE191278T1 (de) Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen
Hawkins et al. Extraction methods for preparing thromboplastin reagents
Takahashi et al. Fast functional assay of protein C in whole plasma using a snake venom activator: evaluation in patients with congenital and acquired protein C deficiencies
Walenga et al. Automated clot-based methods in coagulation testing: current and future considerations
ATE200710T1 (de) Verfahren zur diagnose von blutgerinnungsstörungen
Dati et al. RESULTS OF THE MULTICENTRIC EVALUATION OF A NEW SYSTEM FOR PHOTOMETRIC DETERMINATION OF COAGULATION PARAMETERS
Bartl et al. APPLICATION OF THE ROUTINE PHOTOMETRIC COAGULATION ASSAYS PT, APTT AND FIBRINOGEN TO A CENTRIFUGAL ANALYZER
Baele et al. Comparison of a Recombinant Thromboplastin with Thrombotest® for Oral Anticoagulant Control
McKernan et al. THE RELIABILITY OF THE INTERNATIONAL NORMALISED RATIO (INR) DURING SHORT TERM ORAL ANTICOAGULANT TREATMENT
KOBAYASHI et al. Relation between protein C amidolytic activity and liver function in patients with liver cirrhosis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202